Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.
about
Emerging Issues in AAV-Mediated In Vivo Gene Therapy.Targeted in vivo knock-in of human alpha-1-antitrypsin cDNA using adenoviral delivery of CRISPR/Cas9.Lessons learned from lung and liver in-vivo gene therapy: implications for the futureGene therapy for hemophilia: what does the future hold?AAVvector-mediated in vivo reprogramming into pluripotency
P2860
Identification of liver-specific enhancer-promoter activity in the 3' untranslated region of the wild-type AAV2 genome.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
Identification of liver-specif ...... of the wild-type AAV2 genome.
@en
type
label
Identification of liver-specif ...... of the wild-type AAV2 genome.
@en
prefLabel
Identification of liver-specif ...... of the wild-type AAV2 genome.
@en
P2093
P2860
P50
P356
P1433
P1476
Identification of liver-specif ...... n of the wild-type AAV2 genome
@en
P2093
Allison P Dane
Anais K Amaya
Christine M Smyth
David W Russell
Emilie E Wilkie
Grant J Logan
Martí Cabanes-Creus
Natsuki Sasaki
Neeta Khandekar
P2860
P2888
P304
P356
10.1038/NG.3893
P407
P577
2017-06-19T00:00:00Z
P6179
1086070712